The FINANCIAL — NYSE Euronext (NYX) on November 8 announced trading volumes for its global derivatives and cash equities exchanges for October 2010 [1].
"Global derivatives average daily volume (“ADV”) of 7.5 million contracts traded per day in October 2010 increased 6.2% versus the prior year, but decreased 2.9% from September 2010 levels. The increase in global derivatives ADV versus prior year levels was driven by a 23.8% increase in U.S. equity options ADV, partially offset by an 8.4% decrease in European derivatives ADV. Cash equities ADV in October 2010 were down year-over-year, but both European and U.S. cash trading volumes increased from September 2010 levels by 3.0% and 3.8%, respectively," NYSE Euronext informs.
Highlights
NYSE Euronext global derivatives ADV in October 2010 of 7.5 million contracts increased 6.2% compared to October 2009, but decreased 2.9% from September 2010 levels. Open interest for our European derivatives businesses at the end of October 2010 was 82.0 million contracts, a decrease of 5.5% compared to October 2009, but an increase of 6.7% from September 2010 levels.
NYSE Euronext European derivatives products ADV in October 2010 of 3.5 million contracts decreased 8.4% compared to October 2009 and decreased 16.3% from September 2010 levels. Total European fixed income products ADV in October 2010 of 2.0 million contracts increased 0.2% compared to October 2009, but decreased 10.4% from September 2010. Total equity products ADV of 1.5 million contracts in October 2010 decreased 19.1% compared to October 2009 and decreased 23.7% from September 2010. Total commodities products ADV of 76,000 contracts in October 2010 increased 36.4% compared to October 2009.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in October 2010 increased 23.8% compared to October 2009 levels and increased 13.5% from September 2010. NYSE Euronext’s U.S. options exchanges accounted for 25.9% of the total consolidated equity options trading in October 2010, up from 22.8% in October 2009, but below the 26.1% recorded in September 2010.
NYSE Euronext European cash products ADV of 1.4 million transactions in October 2010 decreased 8.8% compared to October 2009, but increased 3.0% from September 2010.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.4 billion shares in October 2010 decreased 19.1% compared to October 2009, but increased 3.8% compared to September 2010. NYSE Euronext’s Tape A matched market share in October 2010 was 35.2%, down from 36.6% in October 2009 and down from 38.4% in September 2010.
There were a total of 21 trading days in Europe and the U.S. in October 2010 and 22 trading days in Europe and the U.S. in October 2009.
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in October 2010 was 3.5 million futures and options contracts, a decrease of 8.4% from October 2009 and a decrease of 16.3% from September 2010. The 3.5 million in futures and options contracts ADV in October 2010 consisted of 3.1 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 13.6%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
Year-to-date, European derivatives products ADV of 4.9 million contracts was 19.7% above prior year levels. The 4.9 million in futures and options contracts ADV year-to-date consisted of 3.6 million contracts executed through the LIFFE CONNECT trading platform and 1.4 million contracts, or 28.0%, executed through Bclear.
Total fixed income products ADV of 2.0 million contracts in October 2010 increased 0.2% from October 2009, but decreased 10.4% from September 2010. Year-to-date, total fixed income products ADV of 2.4 million contracts was 18.8% above prior year levels.
Total equity products (including Bclear) ADV of 1.5 million contracts in October 2010 decreased 19.1% compared to October 2009 and decreased 23.7% from September 2010. The 1.5 million contracts in equity products ADV consisted of 1.0 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.0 million contracts in individual equity products ADV consisted of 0.3 million in futures contracts, which represented a 10.1% decrease compared to October 2009 and 0.6 million in options contracts, which represented a 23.1% decrease compared to October 2009. The average rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.5 million contracts was 20.3% above prior year levels.
Total commodities products ADV of 76,000 contracts in October 2010 increased 36.4% compared to October 2009. Year-to-date, total commodities product ADV of 64,000 contracts was 34.4% above prior year levels.
U.S. Derivatives
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in October 2010 increased 23.8% compared to October 2009 and increased 13.5% compared to September 2010. Year-to-date, U.S. equity options ADV of 3.7 million contracts was 43.8% above prior year levels.
Total U.S. consolidated equity options ADV increased 9.0% to 15.2 million contracts in October 2010 compared to October 2009 and increased 14.1% compared to September 2010. Year-to-date, U.S. consolidated equity options ADV of 14.2 million contracts was 4.3% above prior year levels.
NYSE Euronext’s U.S. options exchanges accounted for 25.9% of the total U.S. consolidated equity options trading in October 2010, up from 22.8% in October 2009, but down from 26.1% in September 2010.
NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in October 2010 was approximately 12,900 contracts, compared to 22,100 contracts in October 2009. Year-to-date U.S. futures and futures options ADV was 16,200 contracts, a decrease of 5.2% compared to the prior year period.
Cash Trading
European Cash
NYSE Euronext European cash products ADV of 1.4 million transactions in October 2010 decreased 8.8% compared to October 2009, but increased 3.0% compared to September 2010.
Year-to-date, European cash products ADV of 1.5 million transactions was 5.5% above prior year levels.
U.S. Cash
NYSE Euronext U.S. cash products handled ADV in October 2010 decreased 19.1% to 2.4 billion shares compared to October 2009, but increased 3.8% from September 2010.
Year-to-date, U.S. cash products handled ADV was 2.7 billion shares, down 22.4% from prior year levels.
NYSE Euronext’s Tape A matched market share in October 2010 was 35.2%, down from 36.6% in October 2009 and down from 38.4% in September 2010.
Designated Market Maker participation in NYSE-listed stocks in October 2010 was 9.6%, compared to 9.4% in September 2010 and 9.8% in August 2010. Supplemental Liquidity Provider participation in NYSE-listed stocks in October 2010 was 15.4%, compared to 12.4% in September 2010 and 12.2% in August 2010. DMM and SLP participation pertain only to trading on NYSE.
Exchange Traded Products
NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 302 million shares in October 2010 decreased 12.8% compared to October 2009 and was flat compared to September 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 347 million shares was 26.6% below prior year levels.
Discussion about this post